Techprecision Corp TPCS
We take great care to ensure that the data presented and summarized in this overview for TECHPRECISION CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in TPCS
Top Purchases
Top Sells
About TPCS
TechPrecision Corporation, together with its subsidiaries, manufactures and sells precision, fabricated, and machined metal structural components and systems in the United States. The company operates through two segments, Ranor and Stadco. It provides custom components for ships, submarines, military helicopters, aerospace equipment, components for nuclear power plants, and components for medical systems. The company also provides support services to its manufacturing capabilities comprising manufacturing engineering, quality control, materials procurement, production control, and final assembly. Its finished products are used various markets, including defense, aerospace, nuclear, medical, and precision industrial. TechPrecision Corporation was founded in 1956 and is headquartered in Westminster, Massachusetts.
Insider Transactions at TPCS
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jan 24
2025
|
Victor Eugene Renuart Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,720
+50.0%
|
-
|
Jan 24
2025
|
Walter Milton Schenker Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,720
+17.83%
|
-
|
Jan 24
2025
|
Robert D Straus Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,720
+6.03%
|
-
|
Jan 24
2025
|
Andrew A Levy Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,720
+3.11%
|
-
|
Dec 03
2024
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
3,000
-0.72%
|
-
|
Oct 21
2024
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
5,000
-1.18%
|
-
|
Oct 10
2024
|
Richard D. Roomberg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+50.0%
|
-
|
Sep 13
2024
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
3,000
-0.71%
|
-
|
Aug 19
2024
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
10,000
-2.3%
|
-
|
Aug 16
2024
|
Richard Mc Gowan Director |
SELL
Bona fide gift
|
Direct |
6,250
-9.8%
|
-
|
Nov 07
2023
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
15,000
-3.33%
|
-
|
Oct 13
2023
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
2,000
-0.44%
|
-
|
Oct 11
2023
|
Walter Milton Schenker Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+11.21%
|
-
|
Oct 11
2023
|
Andrew A Levy Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+1.36%
|
-
|
Oct 11
2023
|
Richard Mc Gowan Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+13.03%
|
-
|
Oct 11
2023
|
Robert A Crisafulli Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,250
+14.29%
|
-
|
Aug 24
2023
|
Andrew A Levy Director |
SELL
Bona fide gift
|
Direct |
15,000
-3.25%
|
-
|
Jul 17
2023
|
Barbara M. Lilley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
Jul 13
2023
|
Thomas Sammons Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
15,976
-11.9%
|
$111,832
$7.45 P/Share
|
Jul 13
2023
|
Thomas Sammons Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+48.21%
|
$0
$0.68 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 99.9K shares |
---|
Bona fide gift | 27.3K shares |
---|